Skip to content

Effect of ultrasound-guided anterior quadrature lumbar block combined with paracral plexus block on the quality of recovery after total hip replacement in elderly patients

Effect of ultrasound-guided anterior quadrature lumbar block combined with paracral plexus block on the quality of recovery after total hip replacement in elderly patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000028842
Enrollment
Unknown
Registered
2020-01-05
Start date
2020-02-01
Completion date
Unknown
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total hip replacement

Interventions

the intervention group:Ultrasound-guided nerve block

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 65-80 years; 2. ASA grades I ~ III; 3. Can voluntarily cooperate with this research; 4. Simple mental state examination scale (MMSE) score > 24 points; 5. Patients to undergo the first total hip replacement.

Exclusion criteria

Exclusion criteria: 1. Nerve block block contraindications: serious abnormal coagulation function, puncture site infection, etc.; 2. A long history of taking sedatives or other psychotropic drugs; 3. Cannot cooperate with the research for any reason: language comprehension disorder, mental illness, etc.; 4. Severe hearing and visual impairment, unable to cooperate with the completion of the cognitive function test, unable to complete the VAS score; 5. Morbid obesity (body mass index [BMI] > 35 kg/m2); 6. History of allergy to amide local anesthetics; 7. History of chronic chronic pain, long-term use of analgesic drug treatment.

Design outcomes

Primary

MeasureTime frame
Recovery quality score at 24h after surgery (QoR-15);

Secondary

MeasureTime frame
Changes in hemodynamic data;VAS pain grade;MMSE score and CAM-CR score;Dosage: including medication time, drug name and dosage;

Countries

China

Contacts

Public ContactXia Qin

Affiliated Hospital of Xuzhou Medical University

Xq_1203@126.com+86 18375338136

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026